Cardiomyocyte apoptosis contributes to pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated mice

Clinical Science

Volumn 127, Issue 8, 2014, Pages 519-526

  Nam, Soon Woo ^a   Liu, Hongqun ^a   Wong, Joe Z ^a   Feng, Annie Y ^a   Chu, Gavin ^a   Merchant, Naeem ^a   Lee, Samuel S ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Apoptosis; Bax; Bcl 2; Bile duct ligation; Cardiac contractility; Cirrhotic cardiomyopathy; Fas ligand; Poly(ADP ribose) polymerase (PARP)

Indexed keywords

FAS LIGAND; FLICE INHIBITORY PROTEIN; MONOCLONAL ANTIBODY; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BILE DUCT LIGATION; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; HEART FUNCTION; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE CONTRACTILITY; IMAGE ANALYSIS; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; MAGNET; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; PATHOGENESIS; PRIORITY JOURNAL; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BILE DUCTS; BLOTTING, WESTERN; CARDIOMYOPATHIES; FIBROSIS; IMMUNOHISTOCHEMISTRY; LIGATION; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C57BL; MYOCYTES, CARDIAC;

EID: 84903984632     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20130642     Document Type: Article

References (35)

1. Wiese, S., Hove, J. D., Bendtsen, F. and Møller, S. (2013) Cirrhotic cardiomyopathy: pathogenesis and clinical relevance. Nat. Rev. Gastroenterol. Hepatol. 11, 177-186
2. Lee, R. F., Glenn, T. K. and Lee, S. S. (2007) Cardiac dysfunction in cirrhosis. Best. Pract. Res. Clin. Gastroenterol. 21, 125-140
3. Baik, S. K., Fouad, T. R. and Lee, S. S. (2007) Cirrhotic cardiomyopathy. Orphanet J. Rare Dis. 2, 15-23
4. Wyllie, A. H., Kerr, J. F. and Currie, A. R. (1980) Cell death: the significance of apoptosis. Int. Rev. Cytol. 68, 251-306
5. Ghavami, S., Hashemi, M., Kadkhoda, K., Alavian, S. M., Bay, G. H. and Los, M. (2005) Apoptosis in liver diseases-detection and therapeutic applications. Med. Sci. Monit. 11, RA337-RA345
6. Fealy, C. E., Haus, J. M., Solomon, T. P., Pagadala, M., Flask, C. A., McCullough, A. J. and Kirwan, J. P. (2012) Short-term exercise reduces markers of hepatocyte apoptosis in nonalcoholic fatty liver disease. J. Appl. Physiol. 113, 1-6
7. Zamani, A. G., Barlas, I. O., Durakbasi-Dursun, G., Ural, O., Erdal, E. and Yildirim, M. S. (2013) Evaluation of death pathway genes FAS and FASL polymorphisms in chronic HBV infection. Int. J. Immunogenet. 40, 482-487
8. Distefano, G. and Sciacca, P. (2013) Molecular pathogenesis of myocardial remodeling and new potential therapeutic targets in chronic heart failure. Ital. J. Pediatr. 38, 41-51
9. Tostes, Jr, S., Bertulucci Rocha-Rodrigues, D., de Araujo Pereira, G. and Rodrigues, Jr, V. (2005) Myocardiocyte apoptosis in heart failure in chronic Chagas' disease. Int. J. Cardiol. 99, 233-237
10. Chiong, M., Wang, Z. V., Pedrozo, Z., Cao, D. J., Troncoso, R., Ibacache, M., Criollo, A., Nemchenko, A., Hill, J. A. and Lavandero, S. (2012) Cardiomyocyte death: mechanisms and translational implications. Cell Death Dis. 2, e244
11. Hayakawa, Y., Chandra, M., Miao, W., Shirani, J., Brown, J. H., Dorn, II, G. W., Armstrong, R. C. and Kitsis, R. N. (2003) Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Gaq transgenic mice. Circulation 108, 3036-3041
12. Liu, H., Ma, Z. and Lee, S. S. (2000) Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Gastroenterology 118, 937-944
13. Liu, H. and Lee, S. S. (2008) Nuclear factor-kappaB inhibition improves myocardial contractility in rats with cirrhotic cardiomyopathy. Liver Int. 28, 640-648
14. Liu, H. and Lee, S. S. (2005) What happens to cirrhotic cardiomyopathy after liver transplantation? Hepatology 42, 1203-1205
15. Ma, Z. and Lee, S. S. (1996) Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology 24, 451-459
16. Yang, Y. Y., Liu, H., Nam, S. W., Kunos, G. and Lee, S. S. (2010) Mechanisms of TNFa-induced cardiac dysfunction in cholestatic bile duct-ligated mice: interaction between TNFa and endocannabinoids. J. Hepatol. 53, 298-306
17. Glenn, T. K., Honar, H., Liu, H., ter Keurs, H. E. and Lee, S. S. (2011) Role of cardiac myofilament proteins titin and collagen in the pathogenesis of diastolic dysfunction in cirrhotic rats. J. Hepatol. 55, 1249-1255
18. Ashkenazi, A. and Dixit, V. M. (1998) Death receptors: signaling and modulation. Science 281, 1305-1308
19. Green, D. R. (2005) Apoptotic pathways: ten minutes to dead. Cell 121, 671-674
20. Kim, S. J., Eum, H. A., Billiar, T. R. and Lee, S. M. (2013) Role of heme oxygenase 1 in TNF/TNF receptor-mediated apoptosis after hepatic ischemia/reperfusion in rats. Shock 39, 380-388
21. Pobezinskaya, Y. L. and Liu, Z. (2012) The role of TRADD in death receptor signaling. Cell Cycle 11, 871-876
22. Tschopp, J., Irmler, M. and Thome, M. (1998) Inhibition of Fas death signals by FLIPs. Curr. Opin. Immunol. 10, 552-558
23. Liu, L., Azhar, G., Gao, W., Zhang, X. and Wei, J. Y. (1998) Bcl-2 and Bax expression in adult rat hearts after coronary occlusion: age-associated differences. Am. J. Physiol. 275, R315-R322
24. Nicholson, D. W. and Thornberry, N. A. (2003) Apoptosis. Life and death decisions. Science 299, 214-215
25. Szobi, A., Rajtik, T., Carnicka, S., Ravingerova, T. and Adameova, A. (2014) Mitigation of postischemic cardiac contractile dysfunction by CaMKII inhibition: effects on programmed necrotic and apoptotic cell death. Mol. Cell. Biochem. 388, 269-276
26. Los, M., Mozoluk, M., Ferrari, D., Stepczynska, A., Stroh, C., Renz, A., Herceg, Z., Wang, Z. Q. and Schulze-Osthoff, K. (2002) Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. Mol. Biol. Cell 13, 978-988
27. Chaitanya, G. V., Steven, A. J. and Babu, P. P. (2010) PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun. Signal. 8, 31
28. Nadal-Ginard, B., Kajstura, J. and Leri, A. (2003) Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ. Res. 92, 139-150
29. Ibe, W., Saraste, A., Lindemann, S., Bruder, S., Buerke, M., Darius, H., Pulkki, K. and Voipio-Pulkki, L. M. (2007) Cardiomyocyte apoptosis is related to left ventricular dysfunction and remodelling in dilated cardiomyopathy, but is not affected by growth hormone treatment. Eur. J. Heart Fail. 9, 160-167
30. Li, Y., Takemura, G. and Kosai, K. I. (2004) Critical roles for the Fas/Fas ligand system in postinfarction ventricular remodeling and heart failure. Circ. Res. 95, 627-636
31. Masri, C. and Chandrashekhar, Y. (2008) Apoptosis: a potentially reversible, meta-stable state of the heart. Heart Fail. Rev. 13, 175-179
32. Lee, Y. and Gustafsson, A. B. (2009) Role of apoptosis in cardiovascular disease. Apoptosis 14, 536-548
33. Canbay, A., Friedman, S. and Gores, G. J. (2004) Apoptosis: the nexus of liver injury and fibrosis. Hepatology 39, 273-278
34. Jaeschke, H. and Lemasters, J. J. (2003) Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 125, 1246-1257
35. Mitchell, C., Mahrouf-Yorgov, M., Mayeuf, A., Robin, M. A., Mansouri, A., Fromenty, B. and Gilgenkrantz, H. (2011) Overexpression of Bcl-2 in hepatocytes protects against injury but does not attenuate fibrosis in a mouse model of chronic cholestatic liver disease. Lab. Invest. 91, 273-282